Benzinga | Aug 4, 2020 07:19AM EDT

Intersect ENT Q2 Adj. EPS $(0.65) Misses $(0.56) Estimate, Sales $9.78M Beat $5.41M Estimate

Intersect ENT (NASDAQ:XENT) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.56) by 16.07 percent. This is a 80.56 percent decrease over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $9.78 million which beat the analyst consensus estimate of $5.41 million by 80.78 percent. This is a 63.31 percent decrease over sales of $26.66 million the same period last year.